Powered by
BioSyent inches higher, resistance at 12-day EMA February 28, 2017 17:00 EST
Feb 28, 2017 - News Bites Canadian Markets

CANADIAN DAILY STOCK REPORT

BioSyent Inc. (TSXV:RX), Canada's 3rd largest Drug manufacturers company by market cap, has increased 1.3% but fell short of the 12-day Exponential Moving Average [EMA] of CAD7.32. Compared with the S&P/TSX 60 Index which fell 4.8 points (0.5%) in the day, the relative price increase was 1.8%. The volume was 0.5 times the average daily trading volume of 20,102 shares. The stock last traded at CAD7.20.

SECTION 1

BIOSYENT BULLISH SIGNALS

1.1 Fun

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 10 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox